Malaria vs dengue on the topics of investigation needed to diagnosis, signs symptoms
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
I now have comprehensive information from authoritative sources. Let me compile a thorough comparison.
Malaria vs Dengue: Clinical Comparison
Overview
Both are tropical mosquito-borne febrile illnesses that can present similarly at onset, making distinction challenging in the early stages. The key differences lie in their vectors, causative agents, clinical progression, and diagnostic approach.
| Feature | Malaria | Dengue |
|---|---|---|
| Pathogen | Plasmodium spp. (protozoan parasite) | Dengue virus serotypes 1-4 (Flavivirus) |
| Vector | Female Anopheles mosquito | Aedes aegypti (mainly), Aedes albopictus |
| Biting time | Night-biting | Day-biting |
| Incubation | 7-30 days (varies by species) | 4-10 days |
Signs and Symptoms
Malaria
General (all species):
- Fever - classic and most prominent symptom; may be continuous early on
- Headache (sensitivity >95% alongside fever in low-endemicity areas)
- Myalgias and arthralgias
- Nausea, vomiting, diarrhea
- Fatigue and malaise
- Splenomegaly (with repeated or prolonged infection)
- Anemia (pallor, fatigue - from RBC destruction)
Classic periodicity (species-dependent):
- P. vivax and P. ovale: paroxysmal fevers every 48 hours (tertian)
- P. malariae: paroxysms every 72 hours (quartan)
- P. falciparum: often continuous/irregular fever, no classic periodicity
Severe/Complicated Malaria (mainly P. falciparum):
- Cerebral malaria: altered consciousness, coma, seizures
- Hyperparasitemia (>5% parasitised RBCs)
- Hypoglycemia (parasite metabolic activity + quinine effect)
- Lactic acidosis
- Acute renal failure
- Acute Respiratory Distress Syndrome (ARDS)
- Severe anaemia
- Disseminated intravascular coagulation (DIC)/coagulopathy
- Jaundice (hepatic involvement)
- Blackwater fever (massive haemolysis + haemoglobinuria - dark urine)
- Rosen's Emergency Medicine, p. 2660; Washington Manual of Medical Therapeutics, p. 571
Dengue
Dengue is classified into 3 severity phases (WHO 2009):
Phase 1 - Febrile Phase (Days 1-3):
- Abrupt high fever (2-7 days)
- Severe headache
- Retro-orbital pain (pain behind the eyes - characteristic)
- Severe myalgias and arthralgias ("breakbone fever")
- Facial erythema and injected oropharynx
- Macular or maculopapular rash
- Leukopenia (early)
- Petechiae or minor bleeding
- Nausea and vomiting
Phase 2 - Critical Phase (Days 3-7, around defervescence):
- Sudden drop in fever (defervescence) - can falsely appear as improvement
- Increased vascular permeability - plasma leakage
- Rising haematocrit (haemoconcentration)
- Thrombocytopenia (rapid platelet decline)
- Warning signs (need hospitalisation):
- Abdominal pain or tenderness
- Persistent vomiting
- Fluid accumulation (ascites, pleural effusion)
- Mucosal bleeding (gum bleeding, epistaxis, haematemesis)
- Lethargy/restlessness
- Liver enlargement >2 cm
- Rapid decline in platelet count with rising haematocrit
Phase 3 - Severe Dengue:
- Dengue haemorrhagic fever (DHF): severe plasma leakage leading to shock
- Dengue shock syndrome (DSS): hypotension, circulatory collapse
- Severe bleeding (internal or external)
- Severe organ involvement: AST/ALT ≥1000 IU/L, impaired consciousness, cardiac failure
- Less common: myocarditis, pancreatitis, meningoencephalitis, haemophagocytic lymphohistiocytosis
- Red Book 2021 (Committee on Infectious Diseases), p. 520-521; Washington Manual, p. 570; Robbins & Cotran Pathologic Basis of Disease, p. 336
Key Distinguishing Clinical Features
| Feature | Malaria | Dengue |
|---|---|---|
| Fever pattern | Cyclical/paroxysmal (esp. vivax, ovale) | Continuous high fever then sudden defervescence |
| Retro-orbital pain | Absent | Present - characteristic |
| Rash | Usually absent | Maculopapular rash common |
| Muscle/bone pain | Moderate | Severe ("breakbone fever") |
| Bleeding | Rare (DIC in severe falciparum) | Common in severe dengue (DHF) |
| Jaundice | Can occur | Less common |
| Anaemia | Prominent (haemolytic) | Mild if present |
| Splenomegaly | Common | Less prominent |
| Plasma leakage/shock | Rare | Hallmark of severe dengue (DSS) |
| Neurological | Cerebral malaria (falciparum) | Rare encephalitis |
Investigations
Malaria
First-line/Gold Standard:
-
Peripheral blood smear (thick and thin films) - stained with Giemsa or Wright stain
- Thick film: increased sensitivity for detecting parasites (screening)
- Thin film: species identification and parasitaemia quantification
- Serial smears every 12-24 hours if initial smear is negative (parasitaemia may be low early)
- Diagnose based on intraerythrocytic morphology
-
Rapid Diagnostic Tests (RDTs) - e.g., Alere BinaxNOW
- Antigen-based (detects Plasmodium-specific antigens, including HRP-2 for P. falciparum)
- Qualitative, available for ~$5 per test
- Faster but less sensitive than microscopy; a positive RDT must always be confirmed with microscopy for species identification and severity assessment
Supporting investigations:
3. FBC (Full Blood Count): normocytic anaemia, thrombocytopenia, leukopenia or normal WBC
4. Blood glucose: hypoglycaemia common in severe falciparum
5. Renal function (U&E, creatinine): renal failure in severe disease
6. Liver function tests (LFTs): elevated bilirubin, transaminases
7. Lactate: lactic acidosis in severe malaria
8. Coagulation profile (PT, APTT, fibrinogen): DIC screening
9. Blood cultures: to exclude concurrent bacteraemia
10. PCR (molecular testing): most sensitive for species identification and drug resistance; used when smear is negative but malaria still suspected
11. G6PD enzyme assay: required before giving primaquine (for P. vivax/ovale)
12. Urinalysis: haemoglobinuria in blackwater fever
13. Chest X-ray: if ARDS suspected
- Rosen's Emergency Medicine, p. 2661; Washington Manual, p. 571
Dengue
Timing of tests is critical - different tests are useful at different phases:
| Test | When useful | Notes |
|---|---|---|
| RT-PCR (viral RNA) | Days 1-7 (febrile phase) | Most sensitive early; detects virus directly |
| NS-1 antigen (ELISA) | Days 1-7 (febrile phase) | Detects non-structural protein 1; available as rapid test |
| IgM antibody (ELISA) | From Day 3-5 onwards | >99% positive by Day 10; peaks at 2 weeks |
| IgG antibody | Convalescent phase | Lifelong elevation; fourfold rise between acute and convalescent (≥15 days) confirms diagnosis |
Practical approach:
- Single specimen in first 10 days: test both NS-1 antigen AND IgM - identifies ≥90% of primary and secondary cases
- PCR: most specific and useful in first 5 days
- Note: IgM and IgG can cross-react with other flaviviruses (Zika, West Nile, yellow fever, Japanese encephalitis) - interpret with clinical context
Supporting/monitoring investigations:
- FBC: leukopenia (early), then rapid thrombocytopenia (platelet count is the key monitoring parameter)
- Haematocrit/PCV: rising haematocrit = haemoconcentration = plasma leakage = progression to severe dengue
- LFTs: ALT/AST elevation; ≥1000 IU/L = criterion for severe dengue
- Tourniquet test (Rumpel-Leede): inflate BP cuff midway between systolic and diastolic for 5 min; ≥10-20 petechiae per sq. inch = positive; simple, bedside test used in resource-limited settings
- Blood glucose and electrolytes
- Chest X-ray / Ultrasound abdomen: to detect pleural effusion and ascites (plasma leakage)
- Coagulation studies (PT/APTT): if significant bleeding
- Blood cultures: to exclude bacterial co-infection
- Red Book 2021, p. 522-523; Washington Manual, p. 570
Summary Comparison Table: Investigations
| Investigation | Malaria | Dengue |
|---|---|---|
| Definitive test | Peripheral blood smear (Giemsa-stained) | RT-PCR or NS-1 antigen (Days 1-7) |
| Rapid bedside test | RDT (antigen-based, e.g., BinaxNOW) | NS-1 rapid antigen test; Tourniquet test |
| Serology | Not routinely used for acute diagnosis | IgM (Day 3+), IgG (convalescent) |
| FBC | Anaemia, thrombocytopenia, normal/low WBC | Leukopenia then thrombocytopenia |
| Key monitoring parameter | Parasitaemia % on smear | Platelet count + haematocrit trend |
| Glucose | Low (hypoglycaemia - severe falciparum) | Usually normal |
| Liver function | Bilirubin raised (haemolysis) | AST/ALT raised (hepatitis) |
| Renal function | Creatinine raised in severe disease | Usually preserved |
| PCR | Species ID and drug resistance | Serotype ID, Days 1-5 |
| Specific pre-treatment test | G6PD assay (before primaquine) | Not required |
| Imaging | CXR (ARDS) | Ultrasound/CXR for effusions and ascites |
Important Caveats
- Concurrent infection: malaria and dengue can co-exist in endemic areas - one diagnosis does not exclude the other
- Cross-reactivity: dengue serology can cross-react with Zika, West Nile, yellow fever, and Japanese encephalitis viruses
- Travel history is essential for both diagnoses - the specific region of travel influences pre-test probability
- Serial smears: if initial malaria smear is negative but malaria is clinically suspected, repeat every 12-24 hours for 48-72 hours before excluding the diagnosis
- Dengue defervescence trap: patients can appear to improve when the fever breaks on days 3-5, but this marks the start of the dangerous critical phase - close monitoring is needed
This is a shared conversation. Sign in to Orris to start your own chat.